-
Product Insights
NewNet Present Value Model: Quoin Pharmaceuticals Ltd’s QRX-003
Empower your strategies with our Net Present Value Model: Quoin Pharmaceuticals Ltd's QRX-003 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) – Drugs In Development, 2023
Global Markets Direct’s, ‘Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Drugs In Development, 2023’, provides an overview of the Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CTIL-052A in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CTIL-052A in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CTIL-052A in Cervical Cancer Drug Details:C-TIL052A is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-RIPK1 Inhibitor in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-RIPK1 Inhibitor in Autoimmune Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Anti-Ripk1 Inhibitor in Autoimmune Disorders Drug Details:The drug candidate is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QRX-004 in Epidermolysis Bullosa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QRX-004 in Epidermolysis Bullosa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.QRX-004 in Epidermolysis BullosaDrug Details:QRX-004 is under development for the treatment of dystrophic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QRX-003 in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QRX-003 in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.QRX-003 in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)Drug Details:QRX-003...
-
Product Insights
Transdermal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transdermal Drug Delivery Pipeline Market Report Overview Transdermal drug delivery devices are medicated adhesive patches placed on the skin to deliver a specific dose of medication through the skin into the bloodstream. The Transdermal Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Company Profile
Knoll Inc – Company Profile
Knoll Inc (Knoll), a subsidiary of MillerKnoll Inc, manufactures, designs and markets commercial and residential furniture, accessories, lighting and coverings. Its product portfolio comprises system furniture, seating, storage, tables, desks, lounge furniture, cafe and dining chairs, dining and occasional tables, lighting, rugs, textiles and leather, fabrics and architectural products. These products are marketed under the brand names of Knoll, ReGeneration by Knoll, Antenna, Remix, Rockwell Unscripted, Barcelona, Wassily, Womb, Florence Knoll, Life, Reff, Ollo, Quoin and others. The company serves...
Add to Basket -
Product Insights
Net Present Value Model: QRX-003
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model QRX-003 Drug Details QRX-003 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – QRX-003
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry QRX-003 Drug Details QRX-003 is under development for the treatment of Netherton syndrome, peeling...